7301 Stock Overview

Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. More details

7301 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€17M)

Currently unprofitable and not forecast to become profitable over the next 3 years

My Notes

Capture your thoughts, links and company narrative

Flora Growth Corp. Competitors

Rajnish Wellness

BSE:541601

₹1.3b

BillionsLtd

KOSDAQ:A044480

₩20.1b

NutryFarm International

SGX:AZT

S$11.7m

AXIL Brands

NYSEAM:AXIL

US$25.2m

Price History & Performance

Summary of share price highs, lows and changes for Flora Growth
Historical stock prices
Current Share Price	US$0.93
52 Week High	US$1.86
52 Week Low	US$0.76
Beta	1.93
1 Month Change	-22.27%
3 Month Change	-25.40%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-7.50%

Recent updates

Shareholder Returns

	7301	DE Personal Products	DE Market
7D	-45.6%	-2.0%	-2.6%
1Y	n/a	-7.7%	6.9%

Return vs Industry: Insufficient data to determine how 7301 performed against the German Personal Products industry.

Return vs Market: Insufficient data to determine how 7301 performed against the German Market.

Price Volatility

Is 7301's price volatile compared to industry and market?
7301 volatility
7301 Average Weekly Movement	20.5%
Personal Products Industry Average Movement	3.8%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 7301's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 7301's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2019	103	Clifford Starke	www.floragrowth.com

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.

Flora Growth Corp. Fundamentals Summary

How do Flora Growth's earnings and revenue compare to its market cap?
7301 fundamental statistics
Market cap	€16.72m
Earnings (TTM)	-€17.25m
Revenue (TTM)	€61.49m

0.3x

P/S Ratio

-1.0x

P/E Ratio

Is 7301 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7301 income statement (TTM)
Revenue	US$64.15m
Cost of Revenue	US$50.80m
Gross Profit	US$13.35m
Other Expenses	US$31.35m
Earnings	-US$18.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-1.04
Gross Margin	20.81%
Net Profit Margin	-28.05%
Debt/Equity Ratio	43.1%

How did 7301 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 05:51
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Flora Growth Corp. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Rommel Dionisio	Aegis Capital Corporation
Aaron Grey	Alliance Global Partners
Pablo Zuanic	Cantor Fitzgerald & Co.